As part of the broader CBD ban, the Navy bans the use of cannabis shampoo by sailors and marines

Nancy Pelosi says marijuana is a "successful treatment" in the Coronavirus Bill debate
Psychedelic therapists petition the government to allow their own dosage to better treat patients
Nancy Pelosi says marijuana is a "successful treatment" in the Coronavirus Bill debate
The Navy is expanding its Convention on Biological Diversity and cannabis ban on sailors and marines to cover topical products such as shampoos and soaps derived from legal federal crops, surpassing the previous targeting of oils and tinctures. The ban on consumable preparations.
Only four days after the House of Representatives approved an amendment to the spending bill, the update was issued that would allow all members of the military branch to use products containing cannabis and its derivatives (including cannabidiol).
The Navy clarified in a new memo on Friday that the “use of “banned products” “includes the use of topical products that contain cannabis, such as shampoo, conditioner, lotion, lip balm, or soap.” This language did not appear in its earlier cannabis The policy statement includes one released earlier this month.
It is not clear what is behind the expansion of the rule, but although the crop has been legalized by the federal government under the 2018 Farm Act, the military has been continuously warning service personnel to consume hemp-derived cannabinoids.
They expressed concern that because the U.S. Food and Drug Administration (FDA) does not currently regulate commercially available CBD products, there is a risk of mislabeling, and members who accidentally take it may show excessive amounts of tetrahydrocannabis in drug tests. Phenolic products.
The latest memorandum signed by Secretary of the Navy Kenneth J. Braithwaite said: “Sailors and Marines cannot rely on the packaging and labeling of cannabis products to determine whether the product contains products that may lead to the presentation of urinalysis results. Positive THC concentration."
The abuse of drugs by members of the armed forces is inconsistent with the military standards of order, discipline, performance and combat readiness. The goal of the Navy Department (DON) is to eliminate drug abuse. "The use of products that contain, derived from or made from hemp (including CBD), may interfere with the DON drug testing and deterrence program, and lead to the reporting of illegal THC levels in sailors and Marines. "
Violations include “service personnel intending to use any product made or derived from cannabis... regardless of the expected consequences (such as mental or physical effects) of the service member for the use”, and shall be subject to “regardless of product THC concentration "The penalty. , Claims or actual use, regardless of whether the product can be legally purchased, sold and used in accordance with the laws applicable to civilians. "
The notice added that FDA-approved cannabis-derived drugs (such as Epidiolex) prescribed by service personnel are allowed. Sailors and Marines may also still use "durable items containing hemp, such as ropes or clothing."
In February, the U.S. Department of Defense (DOD) announced a policy prohibiting all active and reservists from using cannabis products, including CBD.
Representative Tulsi Gabbard (D-HI) tried to change the status quo by passing amendments to the bill on DOD funding and policies recently passed by the House of Representatives.
This measure will prevent the “Secretary of Defense from prohibiting members of the armed forces from owning, using or consuming such products based on products containing cannabis or any ingredient derived from cannabis” because crops meet the federal definition of cannabis, and “such possession, use or Consumption complies with applicable federal, state and local laws."
However, the Senate did not include the measure in its version of national defense legislation, so the chance for the Senate to pass the bill will fall to the negotiators of the bicameral conference committee, which will prepare the final bill to be sent to the president's desk.
Last year, the Navy issued a preliminary notice informing officers not to use CBD and hemp products regardless of their legality. The memo differs from the latest memo issued last week, saying that the ban “does not apply to topical products such as shampoo, conditioner, lotion or soap.”
It is not clear why the scope has recently been expanded to include non-consumable products.
The Department of Defense reiterated more broadly in an earlier notice issued earlier this year that the CBD prohibits service members regardless of the federal government's legalization of cannabis and its derivatives.
The Ministry of National Defense and the Air Force have weighed this issue before, stipulating that members are prohibited from using CBD derived from hemp.
The Coast Guard says sailors cannot use marijuana or visit state legal dispensaries. The National Aeronautics and Space Administration (NASA) is not a member of the military. He warned that CBD products may contain unauthorized concentrations of THC, and if their drug tests fail, they may kill employees.
Another factor that may affect these policy updates is that the U.S. Administration of Drug Abuse and Mental Health Services issued guidelines to federal agency drug program coordinators last year, outlining the increased levels of THC in CBD products and leading to drug testing Worries of failure.
Oregon officials say Oregon drug decriminalization measures will reduce racial disparities and save money
Activists say that Washington DC officials have enough valid signatures to legalize psychedelics
Kyle Jaeger is the associate editor of Marijuana Moment in Los Angeles. His works have also appeared in High Times, VICE and attn.
Nancy Pelosi says marijuana is a "successful treatment" in the Coronavirus Bill debate
Democratic senators submitted a new bill on Thursday that requires the federal government to legalize marijuana, which provides another potential way for Congress to make policy changes.
The legislation proposed by Senator Tina Smith (D-MN) will remove cannabis from the Controlled Substances Act and direct several federal agencies to formulate regulations on the plant.
Known as the "Material Regulations and Safety Act", the bill will schedule cannabis, require the U.S. Department of Health and Human Services (HHS) to formulate rules that treat cannabis and tobacco equally, and create a national research institution to assess risks and benefits For hemp, the United States Department of Agriculture is required to establish quality control standards, and the Department of Transportation is required to study methods for detecting THC impaired driving.
The scheduling requirement “has retrospective effect and applies to any crimes committed, pending cases or convictions, for minors, any crimes committed, pending cases or judgments on juvenile delinquency, apply to the previous The date of promulgation of the bill in or after,” the text of the bill stated.
HHS must propose a "national strategy to prevent youth use and abuse of cannabis, paying special attention to youth smoking cannabis products." In addition, the text of the law stipulates that the department will be required to "regulate tobacco products in the same way and to the same degree as tobacco. ".
These include "all labeling and advertising requirements that apply to tobacco products under the Act will apply to cannabis products."
The US Customs and Border Protection will work with other agencies to develop policies that allow the import and export of cannabis.
The legislation also contains racial justice provisions. For example, HHS must consult "consult with civil rights stakeholders" within 100 days of the bill's enactment to determine whether "prevention strategies and policies for cannabis abuse may have different effects on race."
The Ministry of Transportation will also have to determine whether its impaired driving prevention policy "may have a racially different impact on the enforcement of the traffic safety law."
After the bill is enacted, the agency responsible for making these regulations will have a year to finalize these regulations.
The bill’s abbreviation, posted on the Congress website, said it would “legalize marijuana and reschedule it.” However, the text of the introduced regulations shared with Cannabis Time says that the complete removal of cannabis from the CSA will go beyond the process of rescheduling the schedule, which is called "reschedule." Representatives from Smith's office did not immediately respond to requests for clarification.
This is the latest legalization bill that this Congress will introduce. In some respects, compared to other legislation supported by reform advocates (such as the Marijuana Opportunities, Reinvestment and Repeal (MORE) Act), this appears to be a milder reform, which includes rescheduling where the most affected Of the community’s reinvestment requirements. The drug war.
Sources recently told "Cannabis Moment" that there are plans to move the bill to a House vote in September, although the prospect of a Republican-controlled Senate is doubtful. Given the narrow focus of Smith’s bill, it may be more palatable to Republican members.
Justin Strekal, political director of NORML, told Marijuana Moment: “It’s great to see Senator Smith participating in the cannabis policy reform debate so substantively.” “At NORML, we look forward to bringing many aspects of the new regulations. Brings in a broad discussion about the future of U.S. federal regulations after the embargo."
The law was introduced a day after the House of Representatives approved an amendment to the spending bill that would protect all states, territories, and tribal cannabis programs from federal interference.
Although Smith has only served in Congress since 2018, after she resigned to replace Senator Al Franken (D-MN), she still signed a number of cannabis reform bills and issued several proposals in favor of reform. comment.
For example, the senator attaches his name to the bill to protect banks that provide services for state legal cannabis businesses from penalties by federal regulators and legalize industrial hemp. She also co-sponsored a resolution condemning the Philippines’ “state-sanctioned extrajudicial executions” of drug crimes.
As Minnesota legislators promote state-level legalization, the bill is about to be introduced, and the top legislator announced in May a comprehensive plan to legalize marijuana for all adults 21 and older.
Not long ago, the Democratic National Committee vetoed legitimization as an amendment to the party platform for 2020, and members chose to accept more moderate reforms. Proponents believe that the group may be under pressure to not formally accept the policy change, while the Democratic presidential nominee Joe Biden opposes this change.
A new Louisiana law greatly expands the state's medical marijuana program, and the law will go into effect on Saturday.
This was two months after the legislature approved the bill and signed the bill by Governor John Bell Edwards (D). The legislation will allow doctors to recommend medical marijuana to patients for any debilitating conditions deemed appropriate, rather than a limited list of diseases used under current law.
Other new laws that will come into effect this weekend include enacting cannabis and CBD regulations, protecting financial institutions that provide services to cannabis companies from penalties by national regulatory agencies, and providing legal protection for doctors in medical cannabis and medical facilities that recommend the use of cannabis. .
The medical marijuana expansion bill proposed by its sponsor, Rep. R. Bagley (R. Bagley), initially only increased brain trauma and concussion, but was modified in the committee to include several other conditions and regulations. The language of cannabis is recommended. Physicians "consider any disease that makes individual patients feel weak."
"I'm very excited. I expect this to be a very important day," Bagley told Cannabis Moments in a telephone interview on Thursday. "All the people here have told me all the wonderful stories of how they suffered great pain, and then they endured it, and then they got rid of the pain."
Legislators particularly hope that by providing patients with safer alternatives to prescription painkillers, providing such an expanded range of use will help curb the epidemic of opioids.
"Medical marijuana is not like opioids because it is not addictive. He said: "No one will die because of it. "
"I hope this will be an important day. I really hope this will become a game changer for Louisiana, the state and the pharmacies that are doing this," he said. "I think this will be a big money maker in the state. At least I hope so. I think everyone will be very happy about it, but time will tell."
Bagley also proposed a bill passed by the House of Representatives to provide delivery services, but he voluntarily withdrew it from the consideration of the Senate committee. At the time, he told Marijuana Moments that he thought this debilitating conditional bill could already be like other bills. The hemp products are delivered to the patients in the traditional way. drug.
The delivery bill will require government regulators to establish “procedures and regulations related to the distribution of cannabis to patients by designated employees or agents of pharmacies.”
Whether the regulator will agree with Bagley's explanation remains to be seen, as doctors are still prohibited from "prescribing" cannabis and cannabis products are not distributed through traditional pharmacies. However, regulators did take measures to temporarily authorize shipping services during the coronavirus pandemic, so it is possible that they will permanently increase the tax allowance.
State legislators also passed a resolution in June establishing a “working group to study and make recommendations regarding the estimated labor demand for the cannabis industry.” The text of the law does not require action by the governor, which states: “It is necessary to study labor Needs and necessary skills to provide a capable and competitive workforce for the cannabis industry, including doctors, nurses, nurses and other medical staff."
Nancy Pelosi says marijuana is a "successful treatment" in the Coronavirus Bill debate
House Speaker Nancy Pelosi (D-CA) defended the decision to include cannabis bank protection measures in the Democrats’ latest coronavirus rescue bill last Friday.
The spokesperson was asked about Republicans criticizing the various provisions of the bill that are not closely related to the health crisis, and a reporter specifically mentioned the ingredients of marijuana. Pelosi objected to this proposal and stated that cannabis reform has played a role in the pandemic.
The Democrats of the Supreme House of Representatives said: "I disagree that marijuana has nothing to do with marijuana." "This is a successful therapy."
It is unclear whether the speaker is suggesting that marijuana has medical value for coronavirus infections, or if he mentioned the plant's therapeutic potential more broadly. The U.S. Food and Drug Administration (FDA) has clearly stated that there is currently no conclusive evidence that cannabinoids can treat COVID-19, and has warned companies that make such claims.
Several parliamentarians believe that the SAFE banking law is related to the health crisis for different reasons, because protecting financial institutions that provide services for marijuana businesses will reduce cash transactions in pharmacies, thereby minimizing the spread of the virus.
Marijuana Moment previously exclusively reported that Pelosi (in 2018 stated that doctors should prescribe marijuana and yoga more frequently instead of prescribing opioids) supported the addition of bank language to the House Coronavirus before legislation is enacted Virus packaging.
Having said that, the Senate leadership announced the latest round of coronavirus mitigation legislation on Monday, but it does not include the provisions of the Foreign Exchange Security Banking Act. It remains to be seen whether the negotiators of both houses will get it in the final bill sent to the president's desk.
Rep. Ed Perlmutter (D-CO) said in May that he thinks the Senate has a 50-50 chance to use it as part of its COVID-19 bill.
On Friday, House Minority Leader Kevin McCarthy (R-CA) took to Twitter to criticize Pelosi’s latest cannabis comments.
Incredibly irresponsible-Pelosi just doubled its $3 trillion cannabis legislation, falsely claiming that it is a proven coronavirus treatment.
"House Democrats are continuing to try to launch unrelated COVID-19 wish list items. The group wrote on Twitter: "All of this should be taken out. "
Democrats in the House of Representatives are continuing to try to launch unrelated COVID-19 wish list items. All of these should be taken out.
At the same time, since the House of Representatives initially approved the bill, the independent "Foreign Exchange Security Banking Act" has continued to serve on the Senate Banking Committee.
Earlier this month, the bipartisan coalition of state finance ministers sent a letter to congressional leaders asking them to incorporate cannabis bank protection measures into the next round of coronavirus relief legislation.
In May, a bipartisan coalition of 34 state attorneys general sent a letter to Congress urging the passage of COVD-19 legislation, which includes marijuana banking regulations.
Pelosi's latest comment comes a day after the House of Representatives approved an amendment to protect state, territory and tribal cannabis laws from federal interference.

Post time: Aug-03-2020

WhatsApp Online Chat !